Introduction
============

Aging is characterized by a gradual decline of the protein homeostasis (proteostasis) network, which affects the levels and conformational stability of proteins ([@B16]; [@B38]), causing the formation of misfolded and toxic aggregates ([@B41]; [@B45]; [@B61]; [@B38]), and ultimately cell death.

Misfolded and oligomeric proteins appear to spread through the brain in characteristic, with robust evidence for the increase of beta amyloid~1-42~ (Aβ), tau, and α-synuclein (α-syn) ([@B33]; [@B25]; [@B23]). In addition, the occurrence of hybrid oligomers ("heteroaggregates") has been shown in both patients' brains and cellular models ([@B51]; [@B58]; [@B2]; [@B14]; [@B23]). In this respect, the levels of the so called "aging-related proteins" have been monitored recently in human red blood cells (RBCs), where α-syn has been shown to interact with Aβ or tau healthy subjects ([@B14]).

Accumulation of toxic, possibly infectious, protein aggregates induces a cascade of events, such as excessive inflammation, the production of ROS, apoptosis and neuronal loss ([@B28]). Moreover, proteinopathy and oxidative stress, together with mitochondrial dysfunction, represent "interacting damage pathways" that culminate in cellular degeneration. In fact, ROS have been demonstrate to enhance the aggregation, of neurodegeneration-related proteins that, in turn, may interact with transition metals or other components to generate further ROS ([@B60]; [@B70]).

Regular physical activity has been emerging as a pivotal factor in counteracting cellular oxidative stress, by exerting anti-inflammatory actions ([@B56]), up-regulating the enzymatic antioxidant system ([@B66]; [@B54]), but also increasing neurogenesis and proteolytic degradation of misfolded proteins ([@B32]; [@B39]; [@B53]). Consequently, it is not surprisingly that exercise has been shown also to impact protein oligomerization; for example, running has been related to a reduced Aβ deposition and tau phosphorylation in mouse brains ([@B9]; [@B5]; [@B62]; [@B37]). Recently, data on such beneficial effects have been emerging in human subjects at a peripheral level, too ([@B15]; [@B18]; [@B9]). In fact, protein accumulation and aggregation has been demonstrated to reach the cerebrospinal and peripheral fluids, too ([@B63]). Therefore, biological changes and putative peripheral biomarkers can be exploited in tissue other than the brain.

In this respect, we have demonstrated that aging-related proteins and in particular α-syn heteromeric interactions with Aβ or tau can be modulated by both oxidative stress and physical exercise ([@B14]).

In order to understand if a specific distribution of misfolded proteins can occur in other blood cells, herein the presence and levels of aging-related proteins were investigated in platelets isolated from human subjects, grouped by their level of physical exercise (i.e., athletes and sedentary subjects) and their age (young and older subjects). Specifically, α-syn heterocomplexes with Aβ or tau were measured to unveil their presence and putative pathogenic role in platelets ([@B65]). Moreover, plasma AOC, the primary marker of oxidative stress in aging-related pathologies ([@B50]), was quantified in the same cohort and correlated to the grade of physical exercise.

Materials and Methods {#s1}
=====================

Study Population and Setting of the Study
-----------------------------------------

Endurance athletes (*N* = 45, ATHL, mean age 45.2 ± 13.0 years) and age-sex-matched sedentary volunteers (*N* = 58, SED, mean age 47.6 ± 14.4 years) were recruited from the Sport Medicine Unit of the Department of Clinical and Experimental Medicine of the University of Pisa (**Table [1](#T1){ref-type="table"}**).

###### 

Descriptive analysis of the total population and of the subgroups.

                   Number of subjects (*N*)   Age (y)       BMI          Heart rate   Physical activity level
  ---------------- -------------------------- ------------- ------------ ------------ -------------------------
  Young subjects   55                         36.1 ± 8.8    23.2 ± 1.9   55.7 ± 3.8   9.94 ± 3.92
  Older subjects   48                         58.4 ± 7.4    23.7 ± 2.1   59.3 ± 5.8   8.90 ± 3.20
  ATHL             45                         45.2 ± 13.0   23.8 ± 1.9   50.6 ± 3.8   13.2 ± 2.2^∗^
  SED              58                         47.6 ± 14.4   24.0 ± 1.6   62.3 ± 5.2   6.61 ± 0.64

The data are the mean ± SD. BMI, body mass index; ATHL, athletes, SED, sedentary. Differences between groups (i.e., young vs. older and ATHL vs. SED) were evaluated by One-way ANOVA followed by a Kruskal--Wallis

post hoc

test.

P

-values were adjusted with Sidak's multiple comparison test.

∗

P

\< 0.001 ATHL vs. SED subjects.

Major inclusion criteria were as followed: total plasma cholesterol ranging from 3.1 to 5.8 mmol/L, HDL cholesterol from 0.67 to 1.9 mmol/L, plasma triglycerides from 0.34 to 1.7 mmol/L, body mass index lower than 30 kg/m^2^, diastolic arterial blood pressure lower than 90 mmHg and systolic arterial blood pressure lower than 140 mmHg ([@B14]). Subjects were excluded if they had smoking habits or received drug treatments within the previous 2 months ([@B14]).

Aerobic fitness was evaluated with a maximal graded cycle ergometry test performed by a cardiologist blinded to the other data ([@B68]). Blood pressure and the rate of perceived exertion (RPE) were assessed at the end of each step. The 15-point Borg RPE scale ([@B8]; [@B27]) was used to evaluate the level of intensity for each participant ([@B14]). The scale ranges from 6 to 20, with 6 corresponding to no exertion at all, 7.5 to extremely light, 9 to very light, 11 to light, 13 to somewhat hard, 15 to hard, 17 to very hard, 19 to extremely hard, and 20 to maximal exertion.

The enrolled healthy subjects were divided into younger (≤50 years), older (\>50 years), athletes (ATHL) and sedentary (SED) subgroups (**Table [1](#T1){ref-type="table"}** and see "Results" section). The time period between the last exercise bout and blood sampling was at least 48 h.

This study was approved by the Ethics Committee of the Great North West Area of Tuscany (271/2014 to FF) and it was carried out in accordance with the Declaration of Helsinki. All subjects gave informed consent to participate in the study. Fully informed consent was obtained from each subject entering the study ([@B14]).

Plasma and Platelet Collection
------------------------------

Whole blood from healthy volunteers was collected into a tube containing EDTA as an anticoagulant. The plasma was separated by centrifugation (200 × *g* at 4°C for 10 min), and then stored at -80°C until use.

To obtain platelets, platelet-rich plasma was collected and centrifuged at 7000 × *g* for 10 min at 4°C. The platelet pellets were washed with 0,83% NH~4~Cl and centrifuged at 1500 × *g*. Then, the pellet was washed with 3 ml of PBS, centrifuged and frozen at -20°C.

Co-immunoprecipitation and Western Blotting Analysis
----------------------------------------------------

The α-syn, tau and Aβ expression was assessed as described previously ([@B14]). In brief, platelets (1,8 mg of proteins) were lysed with RIPA buffer ([@B13]) and then resolved by SDS-PAGE (8.5%). Platelets were incubated with primary antibodies to α-syn (α/β-synuclein N-19, SC-7012, Santa Cruz Biotechnology), tau (H-150 SC-5587, Santa Cruz Biotechnology) or Aβ (β-amyloid H-43 SC-9129, Santa Cruz Biotechnology) overnight at 4°C ([@B14]). The primary antibodies were detected using peroxidase- conjugated secondary antibodies and a chemioluminescent substrate (ECL, Perkin Elmer).

To verify α-syn interaction with tau or Aβ, a co-immunoprecipitation assay was employed ([@B13]; [@B14]). Briefly, 0.5 mg of platelet lysate proteins was probed overnight under constant rotation with an anti-α-syn antibody (5 μg/sample), and then immunoprecipitated with protein A-Sepharose. After extensive washing, the immunocomplexes were re-suspended in Laemmli solution, resolved by SDS-PAGE and probed overnight with primary antibodies to α-syn (input), tau or Aβ as above described ([@B14]).

Detection of Total α-synuclein
------------------------------

Total α-syn was detected in platelets, as previously described ([@B20]; [@B14]). In brief, wells were coated using a α-syn full length antibody (sc-10717, Santa Cruz Biotechnology), and non-specific sites were blocked using Bovine Serum Albumine (BSA). Platelet samples (32 μg proteins/100 μl) were added to the wells for 2 h at 25°C. In parallel, recombinant aliquots of α-syn were tested to create a standard curve. After extensive washing, wells were incubated with a different α-syn antibody (Santa Cruz, sc-12767), and subsequently with an anti-mouse-HRP antibody ([@B14]). The samples were washed with PBS-T (phosphate buffered saline containing 0.01% Tween 20), and incubated with the enzyme substrate TMB (3,3′,5,5′-tetramethylbenzidine, Thermo Scientific). Absorbance values were read at 450 nm.

Detection of Total Aβ
---------------------

Aβ levels in platelets were assessed using an immunoenzymatic assay, as previously described ([@B52]; [@B14]). A specific anti-Aβ antibody (Santa Cruz, sc-9129) was used for 96-well coating at 4°C. After extensive washing with PBS-T, non-specific sites were blocked with 1% BSA. Platelets (80 μg proteins/100 μl) were added to each well and incubated at 25°C for 1 h. After extensive washing with PBS-T, samples were detected using the polyclonal Aβ antibody (sc-5399, Santa Cruz Biotechnology). The standard curve was achieved using solutions of recombinant human Aβ protein at eight different concentrations ([@B14]).

Detection of Total Tau
----------------------

Tau levels in platelets were determined using an immunoenzymatic assay, as previously described ([@B52]; [@B14]). In brief, platelets (32 μg proteins/100 μl) were added to each well pre-coated with a specific anti-tau antibody (Santa Cruz, sc-32274). Then, samples were probed with a different tau antibody (sc-5587, Santa Cruz Biotechnology). In parallel, solutions of recombinant human tau protein were used to obtain a standard curve.

Detection of α-syn-Aβ Heterocomplexes
-------------------------------------

The degree of α-syn-Aβ interactions were quantified, as previously described ([@B14]). In brief, standard α-syn-Aβ were prepared in 2 mM sodium dodecyl sulfate (SDS) in parafilm-sealed tubes at 37°C for 36 h in an "Eppendorf Thermomixer" with continuous mixing (500 rpm) ([@B42]; [@B14]).

Platelets (800 μg/sample) were added to wells pre-coated with the β-amyloid H-43 antibody (1:100, sc-9129, Santa Cruz Biotechnology) at 25°C for 2 h. Non-specific sites were blocked with 1% BSA for 30 min at 37°C. The degree of α-syn bound to Aβ was detected using a specific antibody against α-syn (sc-12767, Santa Cruz Biotechnology), and subsequently an appropriate HRP-conjugated antibody ([@B14]). Relative concentration of α-syn/Aβ complexes were calculated according to the standard curve obtained in each microplate ([@B14]).

Detection of α-syn-Tau Heterocomplexes
--------------------------------------

Standard samples of α-syn-tau were prepared in 2 mM SDS ([@B14]). Wells were pre-coated with anti-α-syn antibody (1:100, sc-7012, Santa Cruz Biotechnology) and incubated with platelet samples (800 μg/sample) at 25°C for 2 h. Non-specific sites were blocked with 1% BSA for 30 min at 37°C. The wells were probed with a specific tau antibody (sc-5587, Santa Cruz Biotechnology), and subsequently with the appropriate HRP-conjugated antibody ([@B14]). Relative concentration of α-syn/tau complexes were calculated according to the standard curve obtained in each microplate ([@B14]).

Total Oxyradical Scavenging Capacity (TOSC) Assay
-------------------------------------------------

The plasma antioxidant capability (AOC) was assessed by the TOSC assay, a gas chromatographic assay for determining oxyradical scavenging capacity of biological fluids ([@B69]; [@B55]; [@B14]). Peroxynitrite was generated from the decomposition of SIN-1 (3-morpholinosyd-nonimine *N*-ethylcarbamide) in the presence of 0.2 mM KMBA \[α-cheto-γ-(methylthiol)butyric acid\], 100 mM potassium phosphate buffer, pH 7.4, and 0.1 mM DTPA (Diethylene Triamine Penta Acetic Acid), at 35°C. The concentration of SIN-1 was varied to achieve an ethylene yield equivalent to the iron--ascorbate and ABAP systems. Reactions with 0.2 mM KMBA were carried out in 10 ml vials sealed with gas-tight Mininert1 valves (Supelco, Bellefonte, PA, United States) in a final volume of 1 ml. TOSC values were quantified from the equation TOSC = 100 - (SA/CA × 100), where SA and CA, are respectively, the area under the curve (AUC) for sample and control reaction. A TOSC value of 0 corresponds to a sample with no scavenging capacity ([@B55]; [@B21]; [@B14]).

Statistical Analysis
--------------------

Data are expressed as mean value ± SD. The population included in this study presented a normal distribution for age. Differences between groups (i.e., young vs. older and ATHL vs. SED) were evaluated by One-way ANOVA followed by a Kruskal--Wallis *post hoc* test. *P*-values were adjusted with Sidak's multiple comparison test. Correlation between variables was determined by simple linear regression analysis, while covariate analysis was performed by partial correlation matrix. All statistical procedures were performed using the StatView program (Abacus Concepts, Inc., SAS Institute, Cary, NC, United States) ([@B22]; [@B14]).

Results
=======

Descriptive Statistics
----------------------

The whole cohort (*N* = 103) was divided in four subgroups (young SED, young ATHL, older SED and older ATHL), whose clinical characteristics are reported in **Table [1](#T1){ref-type="table"}**. The mean age of young and older cohort was of 36.1 ± 8.8 and 59.4 ± 7.4, respectively. No significant differences in age, sex and body mass index (BMI) was found between ATHL and SED. As expected, the level of physical activity was significantly higher in the ATHL group than the SED group (*P* \< 0.001).

Expression of α-syn, tau, Aβ Proteins and of α-syn-Tau and α-syn-Aβ Heterocomplexes in Human Platelets
------------------------------------------------------------------------------------------------------

Western blotting analysis was used to investigate the presence of α-syn, tau and Aβ proteins in platelets isolated from healthy subjects. As depicted in **Figure [1A](#F1){ref-type="fig"}**, the anti-α-syn antibody produced two bands at 15 and 30 kDa (**Figure [1A](#F1){ref-type="fig"}**, middle panel), matching α-syn ([@B7]), whereas the anti-tau antibody recognized three immunoreactive bands ranging between 55 and 74 kDa ([@B10]). These data confirm that platelets have detectable levels of tau and α-syn ([@B46]; [@B47]). Finally, the anti-Aβ antibody recognized two bands at 5 and 15 kDa proteins (**Figure [1A](#F1){ref-type="fig"}**, bottom panel), corresponding to Aβ monomeric and oligomer forms, respectively ([@B11]; [@B48]).

![Presence of α-syn, Aβ, tau, and their heterocomplexes in platelets. **(A)** Cell lysates obtained from platelets were subjected to western blot analysis using antibody against α-syn, Aβ, or tau. GAPDH was the loading control. **(B)** Cell lysates obtained from platelets were immunoprecipitated with an anti-α-syn antibody and then immunoblotted with an α-syn, Aβ, or tau specific antibodies. One representative western blot is presented for each condition.](fnagi-10-00017-g001){#F1}

Next, α-syn interaction with Aβ and tau in platelets was verified using a co-immunoprecipitation-western blotting assay (**Figure [1B](#F1){ref-type="fig"}**). In particular, cell lysates were immunoprecipitated using an anti-α-syn antibody, and then an immunoblot analysis was performed using an anti-tau or anti-Aβ antibody. In parallel, immunoprecipitates were blotted with the same α-syn antibody.

As expected, in α-syn immunoprecipitates (**Figure [1B](#F1){ref-type="fig"}**, upper panel), two bands of 15 and 30 kDa were recognized by the anti-α-syn antibody. When α-syn immunoprecipitates were probed with an anti-tau antibody (**Figure [1B](#F1){ref-type="fig"}**, middle panel), three immunoreactive bands ranging between 55 and 74 kDa were immunodetected ([@B10]). Additional bands, with a molecular weight lower than 50 kDa, could be related to truncated or cleaved forms of tau containing the C-terminal region ([@B57]; [@B14]). Finally, the Aβ immunoblotting performed on α-syn immunoprecipitates (**Figure [1B](#F1){ref-type="fig"}**, bottom panel) revealed multiple bands indicating monomeric and oligomeric Aβ forms (**Figure [1B](#F1){ref-type="fig"}**) ([@B48]). These data demonstrated that α-syn physically interacted with Aβ and tau in platelets, as previously demonstrated in RBCs ([@B14]).

α-syn Quantitative Levels in Human Platelets
--------------------------------------------

α-syn concentrations were determined in platelets isolated from 103 healthy subjects (**Table [2](#T2){ref-type="table"}**). As depicted in **Figure [2A](#F2){ref-type="fig"}**, older subjects presented significant lower α-syn levels with respect to young ones (young vs. older, *P* = 0.0168), suggesting that α-syn may decline with age in platelets. In contrast, no significant differences in total α-syn levels in platelets were noticed between ATHL and SED (*P* = 0.2052, **Figure [2A](#F2){ref-type="fig"}**), suggesting that physical exercise modulated poorly the platelet pool of α-syn.

###### 

Total Oxyradical Scavenging Capacity (TOSC) values against peroxynitrite derivatives; concentrations of total α-syn, Aβ, α-syn/Aβ, tau, and α-syn/tau (as ng/mg of total protein) in the indicate subgroups.

                   TOSC values peroxynitrite   Total α-syn       Aβ          α-syn/Aβ    Tau            α-syn/tau
  ---------------- --------------------------- ----------------- ----------- ----------- -------------- --------------
  Young subjects   18.0 ± 2.0                  362 ± 275         560 ± 484   248 ± 173   170 ± 102      159 ± 99
  Older subjects   17.6 ± 2.7                  235 ± 132^\#\#^   650 ± 500   280 ± 233   214 ± 107      176 ± 161
  ATHL             19.3 ± 1.8                  287 ± 219         697 ± 535   261 ± 197   136 ± 122      114 ± 89
  SED              16.7 ± 2.1^∗∗∗^             372 ± 284         552 ± 470   267 ± 215   218 ± 182^∗^   192 ± 169^∗^

The values are expressed as mean ± SD. ATHL, athletes, SED, sedentary. Differences between groups (i.e., young vs. older and ATHL vs. SED) were evaluated by One-way ANOVA followed by a Kruskal--Wallis

post hoc

test.

P

-values were adjusted with Sidak's multiple comparison test.

∗

P

\< 0.05,

∗∗∗

P

\< 0.001 vs. the respective group of ATHL;

\#\#

P

\< 0.01 vs. the respective group of young subjects.

![Quantitative detection of aging-related proteins in platelets. **(A--E)** Platelet levels of total α-syn **(A)**, Aβ **(B)**, tau **(C)**, α-syn/Aβ **(D)**, and α-syn/tau, **(E)** in young, older, ATHL and SED subjects (mean ± SD). Lysates obtained from platelets were subjected to specific immunoassay, as described in the Section "Materials and Methods.". Differences between groups (i.e., young vs. older and ATHL vs. SED) were evaluated by One-way ANOVA followed by a Kruskal--Wallis *post hoc* test. *P*-values were adjusted with Sidak's multiple comparison test: ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01 between the indicated subgroups.](fnagi-10-00017-g002){#F2}

Aβ Quantitative Levels in Human Platelets
-----------------------------------------

Aβ platelet levels showed comparable levels between young and older subjects (young vs. older, *P* = 0.5369, **Figure [2B](#F2){ref-type="fig"}**), as well as between ATHL and SED (ATHL vs. SED, *P* = 0.2240, **Figure [2B](#F2){ref-type="fig"}**).

These data suggest that age and physical exercise poorly modulate Aβ concentrations in platelets.

Tau Quantitative Levels in Human Platelets
------------------------------------------

Similarly to what observed for Aβ, the platelet concentrations of tau showed comparable levels between young and older subjects (**Figure [2C](#F2){ref-type="fig"}**, young vs. older, *P* = 0.1877).

On the other hand, ATHL showed significantly lower tau levels in platelets with respect to SED in the whole population (total ATHL vs. total SED, *P* = 0.0048, **Figure [2C](#F2){ref-type="fig"}**). These data suggest that tau accumulation in platelets is modulated by physical exercise.

α-syn-Tau and α-syn-Aβ Quantitative Levels in Human Platelets
-------------------------------------------------------------

Finally, the concentrations of α-syn-Aβ and α-syn-tau were measured in platelets using a previously standardized immunoenzymatic assay ([@B14]).

As demonstrated in RBCs, platelet α-syn-Aβ or α-syn-tau levels did not differ between young and elderly subjects (*P* = 0.6734 and *P* = 0.7762, respectively, **Figures [2D,E](#F2){ref-type="fig"}**).

The degree of α-syn interaction with Aβ in platelets was comparable between ATHL and SED (*P* = 0.9962, **Figure [2D](#F2){ref-type="fig"}**). In contrast, the ATHL subjects presented significantly lower levels of platelet α-syn-tau with respect to SED, regardless of age (**Figure [2E](#F2){ref-type="fig"}**, ATHL vs. SED: *P* = 0.0085), suggesting that α-syn-tau levels in platelets can be modulated by physical activity.

Correlation of ND-Related Proteins with Age
-------------------------------------------

Consistent with the data depicted in **Figure [2A](#F2){ref-type="fig"}**, an inverse correlation with age was evidenced for total α-syn in the whole cohort (total cohort: *P* = 0.0439, *R*^2^ = 0.045, **Figure [3A](#F3){ref-type="fig"}**).

![Correlation between aging-related proteins and age. **(A)** Correlation analysis between Aβ concentrations in platelets and age in whole and sedentary cohort **(B,C)** Correlation analysis between Aβ concentrations in platelets and age in whole and sedentary cohort. **(D)** Correlation analysis between α-syn/Aβ concentrations in platelets and age in the ATHL cohort. **(E)** Correlation analysis between α-syn-tau and age in the SED cohort. Correlation between variables was determined by simple linear regression analysis, using the StatView program (Abacus Concepts, Inc., SAS Institute, Cary, NC, United States). *P* and *R*^2^ values obtained for each correlation are reported in the respective panel.](fnagi-10-00017-g003){#F3}

Conversely, a significant positive correlation between Aβ levels in platelets and age was evidenced in the whole population (*P* = 0.0487, *R*^2^ = 0.038, **Figure [3B](#F3){ref-type="fig"}**) and in SED (*P* = 0.0488, *R*^2^ = 0.062, **Figure [3C](#F3){ref-type="fig"}**).

Surprisingly, significant inverse correlation between age and platelet α-syn-Aβ concentrations was found in ATHL (*P* = 0.0093, *R*^2^ = 0.225 **Figure [3D](#F3){ref-type="fig"}**) but not in SED (*P* = 0.1804). In contrast, α-syn-tau levels in platelets inversely correlated with age in SED (*P* = 0.0493, *R*^2^ = 0.056; **Figure [3E](#F3){ref-type="fig"}**) but not in ATHL (*P* = 0.1804).

Plasma Antioxidant Capacity (AOC) in Healthy Subjects
-----------------------------------------------------

A TOSC assay was used to determine the AOC toward peroxynitrite derivatives in plasma from healthy subjects (**Table [2](#T2){ref-type="table"}**); higher mean levels from this assay are related to a better antioxidant capability ([@B14]).

Young and older subjects showed comparable TOSC values in the total population (young vs. older, *P* = 0.3423, **Figure [4A](#F4){ref-type="fig"}**).

![Determination of plasma AOC in human subjects. **(A)** Plasma total oxyradical scavenging capacity (TOSC) against peroxynitrate derivatives in young, older, ATHL and SED subjects (mean ± SD). Differences between groups (i.e., young vs. older and ATHL vs. SED) were evaluated by One-way ANOVA followed by a Kruskal--Wallis *post hoc* test. *P*-values were adjusted with Sidak's multiple comparison test: ^∗∗∗^*P* \< 0.001 between the indicated subgroups. **(B--E)** Correlation analysis between TOSC values against peroxynitrate derivatives and age or level of physical activity, expressed as physical activity level. Correlation between variables was determined by simple linear regression analysis, using the StatView program (Abacus Concepts, Inc., SAS Institute, Cary, NC, United States). *P* and *R*^2^ values obtained for each correlation are reported in the respective panel.](fnagi-10-00017-g004){#F4}

Nevertheless, TOSC values showed an inverse correlation with age in the total population (*P* = 0.0315, *R*^2^ = 0.045, **Figure [4B](#F4){ref-type="fig"}**).

Antioxidant capacity toward peroxynitrite derivatives was significantly higher in ATHL group with respect to SED (ATHL vs. SED, *P* \< 0.0001). Consistent with these findings, peroxynitrite TOSC values showed a direct correlation with the level of physical activity (**Figures [4C](#F4){ref-type="fig"}--[E](#F4){ref-type="fig"}**, total cohort: *P* \< 0.0001, *R*^2^ = 0.317; young cohort: *P* \< 0.0001, *R*^2^ = 0.406; older cohort: *P* = 0.0002, *R*^2^ = 0.26). These results confirm that physical exercise can enhance plasma AOC in humans ([@B14]).

Correlation of Aging-Related Proteins with Plasma AOC
-----------------------------------------------------

Plasma AOC toward peroxynitrite derivatives did not show any significant correlations with the platelet levels of tau (*P* = 0.3378), Aβ (*P* = 0.4195), total α-syn (*P* = 0.3704) or α-syn-Aβ (*P* = 0.8515). Interestingly, α-syn-tau levels showed an inverse correlation with TOSC values in the whole cohort (*P* = 0.0420, *R*^2^ = 0.049, **Figure [5A](#F5){ref-type="fig"}**), suggesting that α-syn interaction with tau in platelets can be related to plasma AOC.

![Correlation between ND-related proteins and TOSC values against peroxynitrite derivatives or physical activity level. **(A)** Correlation analysis between α-syn/tau concentrations in platelets and TOSC values against peroxynitrite derivatives in the total cohort. **(B)** Correlation analysis between Aβ concentrations in platelets and TOSC values against peroxynitrite derivatives in SED cohort. **(C)** Correlation analysis between total α-syn concentrations in platelets and physical activity level in older cohort. **(D--F)** Correlation analysis between α-syn/tau concentrations in platelets and physical activity level in total **(D)**, older **(E)** and young **(F)** cohort. Correlation between variables was determined by simple linear regression analysis, using the StatView program (Abacus Concepts, Inc., SAS Institute, Cary, NC, United States). *P* and *R*^2^ values obtained for each correlation are reported in the respective panel.](fnagi-10-00017-g005){#F5}

Moreover, an inverse correlation was evidenced between platelet Aβ levels and TOSC values in the SED population (*P* = 0.0333, *R*^2^ = 0.099, **Figure [5B](#F5){ref-type="fig"}**), suggesting that Aβ accumulation in platelets may be related to plasma AOC in the presence of a low level of physical activity.

Correlation of Aging-Related Proteins with Physical Activity
------------------------------------------------------------

The physical activity level was not significantly related to the platelet levels of tau (whole cohort: *P* = 0.4107; older group: *P* = 0.1903), Aβ (whole cohort. *P* = 0.1694; older group: *P* = 0.7456; young group: *P* = 0.1068), or α-syn-Aβ (whole cohort: *P* = 0.9880; older group: *P* = 0.1033; young group: *P* = 0.1291). Conversely, total α-syn concentrations were inversely related to the level of physical activity in the older group (*P* = 0.0429, *R*^2^ = 0.040, **Figure [5C](#F5){ref-type="fig"}**), but not in the total cohort (whole cohort: *P* = 0.2688) or in the young one (*P* = 0.3072).

Interestingly, α-syn-tau concentrations showed an inverse correlation with the level of physical activity, regardless of age (**Figures [5D](#F5){ref-type="fig"}--[F](#F5){ref-type="fig"}**, whole cohort: *P* = 0.0429, *R*^2^ = 0.040; older group: *P* = 0.0157, *R*^2^ = 0.169; young group: *P* = 0.0045, *R*^2^ = 0.022). These data are consistent with those reported in **Figure [3E](#F3){ref-type="fig"}**, and confirm that α-syn interaction with tau in platelets can be modulated negatively by physical exercise.

Covariate Analysis
------------------

The partial correlation analysis (**Table [3](#T3){ref-type="table"}**) showed that the TOSC values toward peroxynitrite derivatives were influenced primarily from age. In turn, TOSC values predicted the platelet α-syn-tau levels.

###### 

Partial correlation matrix between the analyzed variables.

                              Age      Physical activity level   TOSC values peroxynitrite   α-syn-Aβ   Aβ       Total α-syn   α-syn-tau   Tau
  --------------------------- -------- ------------------------- --------------------------- ---------- -------- ------------- ----------- --------
  Age                         1,000    -0,185                    -0,001                      0,070      0,181    -0,189        0,016       -0,037
  15 point Borg RPE scale     -0,185   1,000                     0,520                       -0,007     0,329    -0,090        -0,137      -0,027
  TOSC values peroxynitrite   -0,001   0,520                     1,000                       0,053      -0,161   -0,019        -0,029      -0,081
  α-syn-Aβ                    0,070    -0,007                    0,053                       1,000      -0,164   -0,017        -0,073      -0,129
  Aβ                          0,181    0,329                     -0,161                      -0,164     1,000    -0,057        -0,272      -0,361
  Total α-syn                 -0,189   -0,090                    -0,019                      -0,017     -0,057   1,000         -0,180      -0,165
  α-syn-tau                   0,016    -0,137                    -0,029                      -0,073     -0,272   -0,180        1,000       -0,500
  Tau                         -0,037   -0,027                    -0,081                      -0,129     -0,361   -0,165        -0,500      1,000

Interestingly, among all the analyzed variables, α-syn-Aβ concentrations in platelets were significantly decreased by physical exercise.

Discussion
==========

In the present paper, aging-related proteins were detected in platelets of healthy subjects (*N* = 103), and correlated to the subject AOC and to the level of physical exercise. The main findings of this work are the follows: (i) α-syn declined in older subjects, whereas Aβ directly correlated with increasing age; (ii) total α-syn and Aβ concentrations showed an inverse correlation with AOC toward peroxynitrite derivatives in elderly and sedentary subjects, respectively; (iii) tau levels decreased in athletes; (iv) α-syn directly interacted with Aβ and tau in platelets; (v) α-syn interaction with tau was inversely related to peroxynitrite AOC and to the level of physical activity. These results suggest that α-syn heterocomplexes, particularly with tau, could represent novel indicators to monitor aging-related proteins in platelets.

The loss of protein homeostasis that physiologically occur with age is characterized by the accumulation of at least one particular protein into a well-organized fibrillary structure called amyloid ([@B12]). In the case of brain aging, misfolded proteins can reach the blood compartment as the result of oligomer transfer across the blood brain barrier ([@B15]; [@B73]; [@B18]).

The accumulation and toxicity of aging-related proteins have been demonstrated to increase with raising oxidative stress in transgenic animal models and cultured cells (reviewed in [@B72]; [@B1]), leading a critical vicious circle.

On the other hand, several data support the notion that regular physical activity counteracts oxidative stress ([@B32]; [@B39]; [@B53]) and reduces protein oligomerization in mouse brains ([@B9]; [@B5]; [@B62]; [@B37]). Recently, data on such beneficial effects have been emerging in human subjects too ([@B15]; [@B18]; [@B9]).

Recently, we have investigated the influence of physical activity and antioxidant capability on the accumulation of aging-related proteins in human RBCs ([@B14]), which represent a good peripheral model to monitor oxidative stress ([@B35]; [@B44]).

Herein, to unveil putative differences among the blood pools of aging-related proteins, the aforementioned parameters were examined in platelets, too.

To this purpose, a cohort of 103 healthy subjects was enrolled in the present study. Platelets were isolated from peripheral blood, and the levels of α-syn, Aβ tau, and of their heterocomplexes, were measured by immunoenzymatic assays, and related to the extent of the antioxidant capability or of physical exercise.

In our cohort, the plasma AOC was evaluated against peroxynitrite derivatives, in order to extend the data obtained toward hydroxyl and peroxyl species ([@B14]). TOSC values confirmed an inverse correlation with age in the total population and in the sedentary cohort, as reported previously ([@B29]; [@B26]). Moreover, AOC toward peroxynitrite derivatives correlated directly with the level of physical activity, regardless of subjects' age. These results confirm that regular physical exercise can enhance plasma AOC in humans ([@B19]; [@B56]; [@B14]), and that the latter parameter is independent form the examined radical specimen.

Then, platelets were confirmed to express the age-related proteins α-syn, Aβ, tau ([@B11]; [@B7]; [@B47]; [@B48]).

The levels of total α-syn decreased with age in the whole population, consistent with the data reported for α-syn in RBCs and plasma of healthy subjects or PD patients ([@B44]; [@B67]; [@B36]; [@B71]). Conversely, platelet Aβ levels directly correlated with age, as previously reported in RBCs ([@B34]; [@B14]). Considering the role of Aβ in the thrombosis formation ([@B59]), such age-dependent accumulation in human platelets could account, at least in part, for the enhanced thrombosis risk in the elderly.

Aβ concentrations inversely correlated with plasma AOC in SED, suggesting this protein as a marker of oxidative stress in peripheral cells. Consistent with this hypothesis, blood Aβ levels have been demonstrated to positively correlate with an oxidative stress marker ([@B34]).

Then, the influence of physical exercise in ATHL and SED was examined. No significant differences between ATHL and SED were found for total α-syn levels in platelets, suggesting that platelet α-syn concentrations are poorly related to physical activity. In contrast, exercise has been shown to induce a significant reduction in the brain accumulation of α-syn ([@B30]), and α-syn levels in RBCs have been found significantly different in ATHL and SED, especially in the elderly cohort ([@B14]). These data may suggest that the correlation between brain and peripheral fluid is cell-dependent, and, specifically, may be explained considering that α-syn is mainly expressed in RBCs ([@B6]).

The modest influence of exercise on the platelet pool of protein was confirmed for Aβ in the present study. In contrast, significant differences have been reported in RBCs ([@B14]) and in plasma ([@B9]) of healthy subjects. Consistent with the latter's data, voluntary exercise has been recently shown to promote glymphatic clearance of Aβ in aged mice.

In this respect, a huge amount of literature data (reviewed in [@B17]), report the beneficial effects of physical activity on cognitive function and memory, both in transgenic mice of neurodegeneration and in patients affected by Alzheimer's disease or Mild Cognitive Impairment. Globally, the comparison between the data obtained in this study and literature datasuggest that a different modulation of the Aβ platelet pool may occur with respect to other central or peripheral fluids. Further subjects will be needed to confirm the data on Aβ accumulation in blood cells and to understand the biological significance of these findings, both in healthy subject and in patients affects by NDs.

Interestingly, ATHL showed significantly lower tau levels in platelets with respect to SED in the whole population, suggesting that tau accumulation in platelets is modulated by physical exercise. Analogous data have been reported in RBCs of healthy subjects ([@B14]). Similarly, aerobic exercise has been related to a reduction of phosphorylated tau protein in cerebrospinal fluid in older adults with mild cognitive impairment ([@B4]) and in transgenic mice ([@B49]).

Next, the presence of α-syn associated to Aβ or tau was investigated in human platelets. α-syn was demonstrated to co-localize with tau and Aβ in platelets, as previously demonstrated in neurons or in cultured cells ([@B31]; [@B43]; [@B24]; [@B40]; [@B42]; [@B64]; [@B3]) and in RBCs ([@B14]). As demonstrated in the latter cells, α-syn-Aβ or α-syn-tau levels in platelets did not differ between young and elderly subjects. Nevertheless, an inverse correlation between the platelet concentrations of α-syn heterocomplexes and age was found in ATHL. These data suggest that regular exercise influences the accumulation of α-syn heterocomplexes in an age-dependent manner.

α-syn-tau levels showed an inverse correlation with TOSC values and with the level of physical activity in the whole cohort, regardless of age, demonstrating that α-syn interaction with tau in platelets can be modulated by both AOC and physical exercise. Interestingly, in RBCs physical exercise has been shown to regulate α-syn interaction with Aβ rather than with tau ([@B14]). These findings may suggest that regular exercise can exert a different modulation on α-syn heteromeric interaction, depending on the protein localization in blood.

On the light of our data, the correlation between antioxidant capability, regular activity and aging-related proteins in platelets seems to be modest with respect to that reported in brain or RBCs. This may probably account for the higher susceptibility to oxidative stress that has been reported for RBCs with respect to platelets. Further investigations could compare, in the various blood cells, the expression and activity of the enzyme related to the antioxidant system or the production and trafficking of aging-related proteins. Moreover, in such future studies the conformational state of the measured proteins will be explored.

In interpreting our data, it should be considered that these findings were obtained in platelets of a cohort of healthy subjects. The changes in the levels of aging-related proteins and α-syn heterocomplexes could not have a prognostic role in neurodegeneration, yet.

Conclusion
==========

The positive effect of plasma AOC and regular physical exercise on the accumulation of aging-related proteins in platelets was confirmed partially in the present paper. Most importantly, for the first time, α-syn was demonstrated to interact with Aβ and tau human platelets. In particular, this study evidenced the great modulation of α-syn interaction with tau rather than with Aβ in human platelets, probably because of the main presence of tau in these cells with respect to RBCs. These data open the way to new studies aimed at establishing the putative correlation between peripheral and central levels of α-syn heterocomplexes and their role in pathological conditions.
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Aβ
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